Your browser doesn't support javascript.
loading
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Pender, Michael P; Csurhes, Peter A; Smith, Corey; Beagley, Leone; Hooper, Kaye D; Raj, Meenakshi; Coulthard, Alan; Burrows, Scott R; Khanna, Rajiv.
Afiliação
  • Pender MP; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia m.pender@uq.edu.au.
  • Csurhes PA; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.
  • Smith C; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Beagley L; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Hooper KD; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Raj M; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Coulthard A; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Burrows SR; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Khanna R; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Mult Scler ; 20(11): 1541-4, 2014 Oct.
Article em En | MEDLINE | ID: mdl-24493474
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Herpesvirus Humano 4 / Linfócitos T CD8-Positivos / Infecções por Vírus Epstein-Barr / Esclerose Múltipla Crônica Progressiva Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Herpesvirus Humano 4 / Linfócitos T CD8-Positivos / Infecções por Vírus Epstein-Barr / Esclerose Múltipla Crônica Progressiva Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article